186 related articles for article (PubMed ID: 22566415)
41. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall.
Kempe A; Daley MF; Barrow J; Allred N; Hester N; Beaty BL; Crane LA; Pearson K; Berman S
Pediatrics; 2005 Jan; 115(1):146-54. PubMed ID: 15629993
[TBL] [Abstract][Full Text] [Related]
42. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Booy R
Vaccine; 2016 Nov; 34(48):5929-5937. PubMed ID: 27780630
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
[TBL] [Abstract][Full Text] [Related]
44. EDITORIAL.
John JF
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):114. PubMed ID: 27141700
[No Abstract] [Full Text] [Related]
45. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
Walker TY; Elam-Evans LD; Singleton JA; Yankey D; Markowitz LE; Fredua B; Williams CL; Meyer SA; Stokley S
MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):874-882. PubMed ID: 28837546
[TBL] [Abstract][Full Text] [Related]
46. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
[TBL] [Abstract][Full Text] [Related]
47. Missed opportunities for adolescent vaccination, 2006-2011.
Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
[TBL] [Abstract][Full Text] [Related]
48. Organizational correlates of adolescent immunization: findings of a state-wide study of primary care clinics in North Carolina.
Moss JL; Gilkey MB; Griffith T; Bowling JM; Dayton AM; Grimshaw AH; Quinn B; Brewer NT
Vaccine; 2013 Sep; 31(40):4436-41. PubMed ID: 23845803
[TBL] [Abstract][Full Text] [Related]
49. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
50. New adolescent vaccination recommendations and how to make them "stick".
Middleman AB
Curr Opin Pediatr; 2007 Aug; 19(4):411-6. PubMed ID: 17630604
[TBL] [Abstract][Full Text] [Related]
51. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
[TBL] [Abstract][Full Text] [Related]
52. Computer-generated recall letters for underimmunized children: how cost-effective?
Lieu TA; Black SB; Ray P; Schwalbe JA; Lewis EM; Lavetter A; Morozumi PA; Shinefield HR
Pediatr Infect Dis J; 1997 Jan; 16(1):28-33. PubMed ID: 9002097
[TBL] [Abstract][Full Text] [Related]
53. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
[TBL] [Abstract][Full Text] [Related]
54. Update on child and adolescent immunizations: selected review of US recommendations and literature.
Katz JA; Capua T; Bocchini JA
Curr Opin Pediatr; 2012 Jun; 24(3):407-21. PubMed ID: 22572761
[TBL] [Abstract][Full Text] [Related]
55. The evaluation of a standardized call/recall system for childhood immunizations in Wandsworth, England.
Atchison C; Zvoc M; Balakrishnan R
J Community Health; 2013 Jun; 38(3):581-7. PubMed ID: 23355104
[TBL] [Abstract][Full Text] [Related]
56. Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis.
Anyiwe K; Richardson M; Brophy J; Sander B
Vaccine; 2020 Feb; 38(7):1825-1833. PubMed ID: 31889607
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
O'Leary ST; Pyrzanowski J; Brewer SE; Sevick C; Miriam Dickinson L; Dempsey AF
Vaccine; 2019 Jun; 37(26):3409-3418. PubMed ID: 31103367
[TBL] [Abstract][Full Text] [Related]
58. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.
Reagan-Steiner S; Yankey D; Jeyarajah J; Elam-Evans LD; Singleton JA; Curtis CR; MacNeil J; Markowitz LE; Stokley S
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(29):784-92. PubMed ID: 26225476
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of childhood immunization reminder/recall systems in urban private practices.
Franzini L; Rosenthal J; Spears W; Martin HS; Balderas L; Brown M; Milne G; Drutz J; Evans D; Kozinetz C; Oettgen B; Hanson C
Pediatrics; 2000 Jul; 106(1 Pt 2):177-83. PubMed ID: 10888689
[TBL] [Abstract][Full Text] [Related]
60. Routine Childhood Vaccines Given From 1 through 18 Years of Age.
Jacobson RM
Mayo Clin Proc; 2020 Aug; 95(8):1780-1795. PubMed ID: 32753151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
